[ES-6] Advanced atopic dermatitis treatment by serum biomarker TARC-guided precise medicine.
The progress of treatment for chronic inflammatory diseases such as rheumatoid arthritis has emphasized significant strategy of remission induction followed by maintained treatment. Regarding atopic dermatitis judgement of disease activity has been depending on just visual inspection because skin diseases are visible. Thymus and activation regulated chemokine (TARC) is a Th2 chemokine which is the most sensitive serum biomarker reflecting disease activity of atopic dermatitis. We can improve our medical quality and maximize the outcome of atopic dermatitis management by measuring serum TARC. And we also realized there are many pitfalls in former atopic dermatitis treatment. Recently elucidation of mechanism of atopic dermatitis leads to evolution of new developed medicine. More precise recognition and management are required to apply such expensive new drugs. I would like to explain significance and utilization of serum biomarker TARC in clinical practice of atopic dermatitis management.